Literature DB >> 28923346

Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes.

T E Kähkönen1, K K Ivaska2, M Jiang2, K G Büki2, H K Väänänen2, P L Härkönen2.   

Abstract

Fibroblast growth factors (FGF) and their receptors (FGFRs) regulate many developmental processes including differentiation of mesenchymal stromal cells (MSC). We developed two MSC lines capable of differentiating to osteoblasts and adipocytes and studied the role of FGFRs in this process. We identified FGFR2 and fibroblast growth factor receptor like-1 (FGFRL1) as possible actors in MSC differentiation with gene microarray and qRT-PCR. FGFR2 and FGFRL1 mRNA expression strongly increased during MSC differentiation to osteoblasts. FGF2 treatment, resulting in downregulation of FGFR2, or silencing FGFR2 expression with siRNAs inhibited osteoblast differentiation. During adipocyte differentiation expression of FGFR1 and FGFRL1 increased and was down-regulated by FGF2. FGFR1 knockdown inhibited adipocyte differentiation. Silencing FGFR2 and FGFR1 in MSCs was associated with decreased FGFRL1 expression in osteoblasts and adipocytes, respectively. Our results suggest that FGFR1 and FGFR2 regulate FGFRL1 expression. FGFRL1 may mediate or modulate FGFR regulation of MSC differentiation together with FGFR2 in osteoblastic and FGFR1 in adipocytic lineage.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipocyte; Fibroblast growth factor; Fibroblast growth factor receptor; Fibroblast growth factor receptor like-1; Mesenchymal stromal cell; Osteoblast

Mesh:

Substances:

Year:  2017        PMID: 28923346     DOI: 10.1016/j.mce.2017.09.015

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

1.  Scaling a Dpp Morphogen Gradient through Feedback Control of Receptors and Co-receptors.

Authors:  Yilun Zhu; Yuchi Qiu; Weitao Chen; Qing Nie; Arthur D Lander
Journal:  Dev Cell       Date:  2020-06-22       Impact factor: 12.270

2.  FGFR2 accommodates osteogenic cell fate determination in human mesenchymal stem cells.

Authors:  Ying Zhang; Ling Ling; Arya Ajay D/O Ajayakumar; Yating Michelle Eio; Andre J van Wijnen; Victor Nurcombe; Simon M Cool
Journal:  Gene       Date:  2022-01-29       Impact factor: 3.913

Review 3.  Identification and characterization of adipose surface epitopes.

Authors:  Yasuhiro Onogi; Ahmed Elagamy Mohamed Mahmoud Khalil; Siegfried Ussar
Journal:  Biochem J       Date:  2020-07-17       Impact factor: 3.857

Review 4.  Fibroblast growth factors signaling in bone metastasis.

Authors:  Estefania Labanca; Elba S Vazquez; Paul G Corn; Justin M Roberts; Fen Wang; Christopher J Logothetis; Nora M Navone
Journal:  Endocr Relat Cancer       Date:  2020-07       Impact factor: 5.678

Review 5.  Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis.

Authors:  Marilena Tauro; Conor C Lynch
Journal:  Cancers (Basel)       Date:  2018-06-05       Impact factor: 6.639

6.  NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression.

Authors:  Stefanie Wittrisch; Nora Klöting; Karin Mörl; Rima Chakaroun; Matthias Blüher; Annette G Beck-Sickinger
Journal:  Mol Metab       Date:  2019-11-16       Impact factor: 7.422

7.  Actomyosin and the MRTF-SRF pathway downregulate FGFR1 in mesenchymal stromal cells.

Authors:  Jip Zonderland; Silvia Rezzola; Lorenzo Moroni
Journal:  Commun Biol       Date:  2020-10-16

8.  Endowing iPSC-Derived MSCs with Angiogenic and Keratinogenic Differentiation Potential: A Promising Cell Source for Skin Tissue Engineering.

Authors:  Weimin Lin; Miao Chen; Chen Hu; Siyu Qin; Chenyu Chu; Lin Xiang; Yi Man; Yili Qu
Journal:  Biomed Res Int       Date:  2018-09-13       Impact factor: 3.411

9.  miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1.

Authors:  Xiangjun Liu; Chengfeng Zhang; Cunhua Wang; Jianwei Sun; Deliang Wang; Yansheng Zhao; Xiaohui Xu
Journal:  Oncol Lett       Date:  2018-06-11       Impact factor: 2.967

10.  Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression.

Authors:  Lan Yu; Mervi Toriseva; Syeda Afshan; Mario Cangiano; Vidal Fey; Andrew Erickson; Heikki Seikkula; Kalle Alanen; Pekka Taimen; Otto Ettala; Martti Nurmi; Peter J Boström; Markku Kallajoki; Johanna Tuomela; Tuomas Mirtti; Inès J Beumer; Matthias Nees; Pirkko Härkönen
Journal:  Cancers (Basel)       Date:  2022-01-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.